Company / PP&E per Share
RHYTHM PHARMACEUTICALS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.02
FY2025
5-year range
$0.01 / $0.06
FY2021-FY2025
Trend
+66.4%
vs FY2024
Sector context
#146 of 191
Health Care
What the data says
RHYTHM PHARMACEUTICALS, INC.'s pp&e per share of $0.02 is lower than 76% of companies in the Health Care sector (FY2025). PP&E per Share returned to growth in FY2025 after 5 years of decline, reaching $0.02.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -24.6%.
Declined from $0.02 to $0.02 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -25.1%
- 5-Year CAGR
- -24.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 191This company $0.02 Sector average $22.34
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 66.4% year-over-year.
- Ranks #146 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +66.4% |
| FY2024 | $0.01 | -55.1% |
| FY2023 | $0.02 | -43.8% |
| FY2022 | $0.04 | -25.7% |
| FY2021 | $0.06 | -21.7% |
| FY2020 | $0.07 | -28.2% |
| FY2019 | $0.10 | +145.5% |
| FY2018 | $0.04 | -50.2% |
| FY2017 | $0.08 | -9.7% |
| FY2016 | $0.09 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026